Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM
Trial details
- Registry ID
- NCT05186818
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as CK-3773274
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCMNCT05186818 | Cytokinetics | Phase 3 | Completed | 2023-11-10Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |